Abstract |
Multiple myeloma (MM) is characterized by accumulation and dissemination of malignant plasma cells (PCs) in the bone marrow (BM). Gene expression profiling of 2 MM cell lines (OH-2 and IH-1) indicated that expression of PRL-3, a metastasis-associated tyrosine phosphatase, was induced by several mitogenic cytokines. Cytokine-driven PRL-3 expression could be shown in several myeloma cell lines at both the mRNA and protein levels. There was significantly higher expression of the PRL-3 gene in PCs from patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma (SMM), and myeloma than in PCs from healthy persons. Among 7 MM subgroups identified by unsupervised hierarchical cluster analysis, PRL-3 gene expression was significantly higher in the 3 groups denoted as "proliferation," "low bone disease," and "MMSET/FGFR3." PRL-3 protein was detected in 18 of 20 BM biopsies from patients with MM. Silencing of the PRL-3 gene by siRNA reduced cell migration in the MM cell line INA-6, but had no detectable effect on proliferation and cell-cycle phase distribution of the cells. In conclusion, PRL-3 is a gene product specifically expressed in malignant plasma cells and may have a role in migration of these cells.
|
Authors | Unn-Merete Fagerli, Randi U Holt, Toril Holien, Thea K Vaatsveen, Fenghuang Zhan, Kjartan W Egeberg, Bart Barlogie, Anders Waage, Harald Aarset, Hong Yan Dai, John D Shaughnessy Jr, Anders Sundan, Magne Børset |
Journal | Blood
(Blood)
Vol. 111
Issue 2
Pg. 806-15
(Jan 15 2008)
ISSN: 0006-4971 [Print] United States |
PMID | 17934070
(Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Neoplasm Proteins
- RNA, Messenger
- RNA, Neoplasm
- PTP4A3 protein, human
- Protein Tyrosine Phosphatases
|
Topics |
- Cell Cycle
(genetics)
- Cell Line, Tumor
- Cell Movement
(genetics)
- Cytokines
(genetics, metabolism)
- Female
- Gene Expression Regulation, Neoplastic
(genetics)
- Gene Silencing
- Humans
- Male
- Multiple Myeloma
(metabolism, pathology)
- Neoplasm Metastasis
- Neoplasm Proteins
(antagonists & inhibitors, biosynthesis, genetics)
- Plasma Cells
(metabolism, pathology)
- Protein Tyrosine Phosphatases
(antagonists & inhibitors, biosynthesis, genetics)
- RNA, Messenger
(biosynthesis, genetics)
- RNA, Neoplasm
(biosynthesis, genetics)
- Randomized Controlled Trials as Topic
|